- Home
- FRD vs DTIL Comparison
FRD vs DTIL Comparison
Compare FRD & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FRD | DTIL |
|---|---|---|
| Founded | 1965 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Steel/Iron Ore | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.3M | 128.8M |
| IPO Year | 1995 | 2019 |
Fundamental Metrics
Financial Performance| Metric | FRD | DTIL |
|---|---|---|
| Price | $17.63 | $6.91 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $60.00 |
| AVG Volume (30 Days) | 22.7K | ★ 210.4K |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.93% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.46 | N/A |
| Revenue | $121,157,278.00 | ★ $1,070,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $48.47 |
| P/E Ratio | $12.05 | ★ N/A |
| Revenue Growth | ★ 55.82 | N/A |
| 52 Week Low | $12.24 | $3.53 |
| 52 Week High | $24.37 | $8.82 |
Technical Indicators
Market Signals| Indicator | FRD | DTIL |
|---|---|---|
| Relative Strength Index (RSI) | 42.37 | 84.07 |
| Support Level | $15.58 | $3.96 |
| Resistance Level | $20.60 | $8.82 |
| Average True Range (ATR) | 0.81 | 0.47 |
| MACD | -0.08 | 0.25 |
| Stochastic Oscillator | 40.40 | 99.04 |
Price Performance
Historical ComparisonAbout FRD Friedman Industries Inc.
Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.